Clinical Trials on Mesothelioma in Switzerland
Total 19 results
-
Swiss Group for Clinical Cancer ResearchCompletedMalignant MesotheliomaSwitzerland
-
University of ZurichSwiss National Science Foundation; Swiss Accident Insurance Fund SUVACompletedMalignant Pleural MesotheliomaSwitzerland
-
University of ZurichCompletedMalignant Pleural MesotheliomaSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompletedMalignant Pleural Mesothelioma, AdvancedSwitzerland, Italy
-
Swiss Group for Clinical Cancer ResearchCompletedMalignant MesotheliomaSwitzerland, Germany
-
Genzyme, a Sanofi CompanyTerminatedMesotheliomaGermany, Switzerland
-
ETOP IBCSG Partners FoundationMerck Sharp & Dohme LLC; Frontier Science Foundation, HellasCompletedPleural Mesothelioma Malignant AdvancedUnited Kingdom, Switzerland, Spain
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingNon-small Cell Lung Cancer | Malignant Pleural MesotheliomaSwitzerland
-
European Organisation for Research and Treatment...ETOP IBCSG Partners FoundationCompletedSPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access (SPECTAlung)Any Stage of Lung Cancer (Any Histotype) | Any Stage of Malignant Pleural Mesothelioma | Any Stage of Any Thymic MalignancySpain, Belgium, Ireland, Slovenia, France, United Kingdom, Poland, Italy, Switzerland
-
Kantonsspital Winterthur KSWCompletedRenal Cell Carcinoma | Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Urothelial Carcinoma | Pleural Mesothelioma | Gastro-Intestinal CancerSwitzerland
-
ETOP IBCSG Partners FoundationHoffmann-La RocheActive, not recruitingPleural Mesothelioma Malignant AdvancedSwitzerland, United Kingdom, Belgium, Spain, France, Italy
-
Dr Jean Yannis PERENTESRecruitingCarcinoma, Non-Small-Cell Lung | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Mesothelioma, Malignant | Carcinoma Breast Stage IVSwitzerland
-
European Organisation for Research and Treatment...CompletedCisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the PleuraMalignant MesotheliomaCanada, France, Switzerland, Belgium, Netherlands, Italy, United Kingdom, Egypt, Germany, Peru, Poland
-
AstraZenecaRecruitingUnresectable Pleural MesotheliomaDenmark, Italy, Australia, Korea, Republic of, Belgium, United States, Canada, Japan, United Kingdom, China, Brazil, France, Taiwan, Spain, Norway, Switzerland, Turkey, Poland, Germany, South Africa, Netherlands
-
Novartis PharmaceuticalsRecruitingMesotheliomaAustralia, Switzerland, Italy, Spain, Canada, Germany, Japan, United Kingdom, Netherlands, United States, France
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedMesotheliomaBrazil, United States, China, Italy, Australia, Belgium, Chile, Colombia, France, Germany, Greece, Japan, Mexico, Netherlands, Poland, Romania, Russian Federation, South Africa, Switzerland, Turkey, United Kingdom
-
Sabine RhodeRuhr University of BochumUnknownGastric Cancer | Colorectal Cancer | Ovarian Cancer | Ascites | Pseudomyxoma Peritonei | Pancreas Cancer | Chemotherapeutic Toxicity | Pleural Effusion | Gallbladder Cancer | CUP | Appendix Cancer | Pleural Mesothelioma | Peritoneum Cancer | Peritoneum Neoplasm | Pleural CancerSingapore, France, Germany, Australia, Argentina, Austria, Belgium, Denmark, Italy, Poland, Russian Federation, Spain, Switzerland
-
Seagen Inc.RecruitingColorectal Neoplasms | Pancreatic Neoplasms | Mesothelioma | Non-small Cell Lung Cancer | Cutaneous MelanomaUnited States, Canada, Switzerland, France, Germany, United Kingdom
-
PharmaMarRecruitingGlioblastoma | Pancreatic Adenocarcinoma | Neuroendocrine Tumors | Advanced Solid Tumors | Mesothelioma | SCLC | Gastric Carcinoma | Endometrial Carcinoma | Colorectal Carcinoma | Gastroenteropancreatic Neuroendocrine Tumor | Epithelial Ovarian Carcinoma | Soft Tissue Sarcoma (Excluding GIST)United States, Spain, France, Germany, Italy, Switzerland